On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Catabolism of arginine: substrate supply
- Catabolism of arginine: the Krebs urea cycle
- Hepatocytes vs. macrophages
- Regulation of iNOS transcription
- Importance of iNOS in mycobacterial disease
- Structure of arginases
- Evidence for Arg1 regulation by Stat6 pathway
- The type I and II IL-4 and IL-13 receptors
- Mechanism of Arg1 regulation by Stat6 pathway
- Regulation of Arg1 by the Stat3 pathway
- Catabolism of arginine: Arg1 vs. iNOS
- The substrate depletion concept
- Norvaline
- Catabolism of arginine, separation of powers
- Arginases, NO and pathogenesis (1)
- Arginases, NO and pathogenesis (2)
- Arginase and in vivo regulation of NO
- Arginase and in vivo regulation of NO (2)
- Schistosome infection and Arg1(1)
- Schistosome infection and Arg1(2)
- Schistosome infection and AAMs
- Severe periportal fibrosis, genetic components (1)
- Severe periportal fibrosis, genetic components (2)
- Macrophage Arg1 is essential for T cell response
- What about macrophage Arg1 in asthma?
- Arginase inhibitors
- Arginase & NO: unresolved questions
- Thank you
Topics Covered
- Catabolism of arginine to downstream substrates
- Catabolism of arginine in macrophages
- Nitric oxide production
- Control of iNOS at the transcriptional level
- Role of nitric oxide in immunity to intracellular pathogens with a focus on mycobacterial disease
- Structure of arginases
- Transcriptional control of arginase 1 in the liver vs. macrophages
- Arginases can suppress nitric oxide production by substrate depletion
- Pathogens use many mechanisms to regulate nitric oxide
- Arginases and alternatively-activated macrophages (AAMs)
- Schistosome infection as an example of AAM function
- AAMs and arginases
- Arginase inhibition by small molecules
- Outstanding questions
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Murray, P. (2011, August 31). Arginase and nitric oxide [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/ZPMW3102.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Peter Murray has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.